Literature DB >> 4169552

Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.

E P Pequegnat, W E Mayberry, W M McConahey, E P Wyse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4169552

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  8 in total

Review 1.  Thyroid eye disease.

Authors:  D H Char
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

Review 2.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

3.  The effect of subtotal thyroidectomy on Graves' ophthalmopathy.

Authors:  M D Levitt; A J Edis; R Agnello; C C McCormick
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

4.  [The problems surrounding subtotal struma resection in hyperthyroidism with endocrinous Ophthalmopathy (author's transl)].

Authors:  J Schumann; V Grabs
Journal:  Langenbecks Arch Chir       Date:  1975-09-10

Review 5.  Radionuclide therapy of the thyroid.

Authors:  S E Clarke
Journal:  Eur J Nucl Med       Date:  1991

Review 6.  Graves' ophthalmopathy.

Authors:  J R Wall; J Henderson; C R Strakosch; D M Joyner
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262

7.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994

Review 8.  Relationship between management of hyperthyroidism and course of the ophthalmopathy.

Authors:  L Bartalena; M L Tanda; E Piantanida; A Lai; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.